| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1009120
[patent_doc_number] => 06899880
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-31
[patent_title] => 'Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia'
[patent_app_type] => utility
[patent_app_number] => 10/155947
[patent_app_country] => US
[patent_app_date] => 2002-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 14151
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/899/06899880.pdf
[firstpage_image] =>[orig_patent_app_number] => 10155947
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/155947 | Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia | May 23, 2002 | Issued |
Array
(
[id] => 6814075
[patent_doc_number] => 20030073625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial IB-367 peptides'
[patent_app_type] => new
[patent_app_number] => 10/075924
[patent_app_country] => US
[patent_app_date] => 2002-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5256
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073625.pdf
[firstpage_image] =>[orig_patent_app_number] => 10075924
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/075924 | Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial IB-367 peptides | Feb 11, 2002 | Abandoned |
Array
(
[id] => 6869980
[patent_doc_number] => 20030082669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Glyoxylate cycle enzymes as targets for antifungal drug development'
[patent_app_type] => new
[patent_app_number] => 10/071894
[patent_app_country] => US
[patent_app_date] => 2002-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5634
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082669.pdf
[firstpage_image] =>[orig_patent_app_number] => 10071894
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/071894 | Glyoxylate cycle enzymes as targets for antifungal drug development | Feb 7, 2002 | Abandoned |
Array
(
[id] => 779266
[patent_doc_number] => 06995134
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-02-07
[patent_title] => 'Use of yneS, essential bacterial genes and polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/068080
[patent_app_country] => US
[patent_app_date] => 2002-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12457
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/995/06995134.pdf
[firstpage_image] =>[orig_patent_app_number] => 10068080
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/068080 | Use of yneS, essential bacterial genes and polypeptides | Feb 4, 2002 | Issued |
Array
(
[id] => 7593358
[patent_doc_number] => 07651842
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-26
[patent_title] => 'Imunogenic complex comprising ribosomes'
[patent_app_type] => utility
[patent_app_number] => 10/250664
[patent_app_country] => US
[patent_app_date] => 2002-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20903
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/651/07651842.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250664
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250664 | Imunogenic complex comprising ribosomes | Jan 3, 2002 | Issued |
Array
(
[id] => 996311
[patent_doc_number] => 06913750
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-05
[patent_title] => 'Therapeutic compounds structurally-linked to bacterial polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/027350
[patent_app_country] => US
[patent_app_date] => 2001-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14278
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/913/06913750.pdf
[firstpage_image] =>[orig_patent_app_number] => 10027350
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/027350 | Therapeutic compounds structurally-linked to bacterial polypeptides | Dec 27, 2001 | Issued |
Array
(
[id] => 1027553
[patent_doc_number] => 06881412
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-04-19
[patent_title] => 'Modified live Flavobacterium columnare against columnaris disease in fish'
[patent_app_type] => utility
[patent_app_number] => 10/020735
[patent_app_country] => US
[patent_app_date] => 2001-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3338
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/881/06881412.pdf
[firstpage_image] =>[orig_patent_app_number] => 10020735
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/020735 | Modified live Flavobacterium columnare against columnaris disease in fish | Dec 11, 2001 | Issued |
Array
(
[id] => 250670
[patent_doc_number] => 07582426
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-01
[patent_title] => 'Method for expression of proteins on spore surface'
[patent_app_type] => utility
[patent_app_number] => 10/433577
[patent_app_country] => US
[patent_app_date] => 2001-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 20
[patent_no_of_words] => 14639
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/582/07582426.pdf
[firstpage_image] =>[orig_patent_app_number] => 10433577
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/433577 | Method for expression of proteins on spore surface | Dec 6, 2001 | Issued |
Array
(
[id] => 1101398
[patent_doc_number] => 06815173
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-09
[patent_title] => 'Method for detecting syphilis using synthetic antigents'
[patent_app_type] => B1
[patent_app_number] => 10/009698
[patent_app_country] => US
[patent_app_date] => 2001-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6636
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/815/06815173.pdf
[firstpage_image] =>[orig_patent_app_number] => 10009698
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/009698 | Method for detecting syphilis using synthetic antigents | Dec 4, 2001 | Issued |
Array
(
[id] => 6278512
[patent_doc_number] => 20020107201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Analogues of lipopolysaccharide-binding protein (LBP)-derived peptides that efficiently neutralize lipopolysaccharides (LPS)'
[patent_app_type] => new
[patent_app_number] => 10/003858
[patent_app_country] => US
[patent_app_date] => 2001-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4706
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20020107201.pdf
[firstpage_image] =>[orig_patent_app_number] => 10003858
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/003858 | Analogues of lipopolysaccharide-binding protein (LBP)-derived peptides that efficiently neutralize lipopolysaccharides (LPS) | Oct 30, 2001 | Abandoned |
Array
(
[id] => 6405087
[patent_doc_number] => 20020037528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Method for detecting procoagulant genetic and metabolic conditions associated with, and potentially predispositional for, activation of the coagulation response'
[patent_app_type] => new
[patent_app_number] => 09/966311
[patent_app_country] => US
[patent_app_date] => 2001-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2293
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20020037528.pdf
[firstpage_image] =>[orig_patent_app_number] => 09966311
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/966311 | Method for detecting procoagulant genetic and metabolic conditions associated with, and potentially predispositional for, activation of the coagulation response | Sep 27, 2001 | Abandoned |
Array
(
[id] => 6063369
[patent_doc_number] => 20020031786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-14
[patent_title] => 'Measurement of analytes in whole blood'
[patent_app_type] => new
[patent_app_number] => 09/961889
[patent_app_country] => US
[patent_app_date] => 2001-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7388
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20020031786.pdf
[firstpage_image] =>[orig_patent_app_number] => 09961889
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/961889 | Measurement of analytes in whole blood | Sep 23, 2001 | Abandoned |
Array
(
[id] => 5710016
[patent_doc_number] => 20060051361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Vaccine against Streptococcus pneumoniae'
[patent_app_type] => utility
[patent_app_number] => 10/380575
[patent_app_country] => US
[patent_app_date] => 2001-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12723
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051361.pdf
[firstpage_image] =>[orig_patent_app_number] => 10380575
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/380575 | Vaccine against Streptococcus pneumoniae | Sep 11, 2001 | Abandoned |
Array
(
[id] => 1094952
[patent_doc_number] => 06821521
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-23
[patent_title] => 'Multicomponent meningococcal vaccine'
[patent_app_type] => B1
[patent_app_number] => 09/830854
[patent_app_country] => US
[patent_app_date] => 2001-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3819
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/821/06821521.pdf
[firstpage_image] =>[orig_patent_app_number] => 09830854
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/830854 | Multicomponent meningococcal vaccine | Aug 28, 2001 | Issued |
Array
(
[id] => 7290727
[patent_doc_number] => 20040110672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Accesory cholera enterotoxin and analogs thereof as activators of calcium dependent chloride channel'
[patent_app_type] => new
[patent_app_number] => 10/333610
[patent_app_country] => US
[patent_app_date] => 2003-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 13286
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110672.pdf
[firstpage_image] =>[orig_patent_app_number] => 10333610
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/333610 | Accessory cholera enterotoxin and analogs thereof as activators of calcium dependent chloride channel | Jul 26, 2001 | Issued |
Array
(
[id] => 6882643
[patent_doc_number] => 20010049115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-06
[patent_title] => 'Vitro model for gastrointestinal inflammation'
[patent_app_type] => new
[patent_app_number] => 09/903690
[patent_app_country] => US
[patent_app_date] => 2001-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3861
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20010049115.pdf
[firstpage_image] =>[orig_patent_app_number] => 09903690
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/903690 | Vitro model for gastrointestinal inflammation | Jul 12, 2001 | Abandoned |
Array
(
[id] => 6760787
[patent_doc_number] => 20030124148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Method for producing autogenous vaccines for treating chlamydial infections in mammals and humans'
[patent_app_type] => new
[patent_app_number] => 09/869436
[patent_app_country] => US
[patent_app_date] => 2001-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1964
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20030124148.pdf
[firstpage_image] =>[orig_patent_app_number] => 09869436
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/869436 | Method for producing autogenous vaccines for treating chlamydial infections in mammals and humans | Jun 27, 2001 | Abandoned |
| 09/762926 | Basb024 outer membrane protein of neisseria menigitidis | Jun 10, 2001 | Abandoned |
| 09/856644 | Method for screening cd14 agonist or antagonist | May 23, 2001 | Abandoned |
| 09/831834 | Method for producing an agent for treating non-cancerous pathologies of the organism | May 14, 2001 | Abandoned |